As the world is currently struggling to contain the pandemic that is the coronavirus, it appears that the situation would only get worse before it could get better. According to Infectious Diseases director Dr. Anthony Fauci, the cases of coronavirus in the United States can be expected to go up to a million, with thousands of fatalities with it.
CNN reports that Dr. Fauci appeared on State of the Union, speaking to anchor Jake Tapper on the situation regarding the coronavirus. The infectious diseases expert predicted that based on models, there would be 100,000 fatalities from the coronavirus in the country. The pandemic has already claimed 2,000 lives as the number of cases has skyrocketed.
“Whenever the models come in, they give a worst-case scenario and a best-case scenario. Generally, the reality is somewhere in the middle. I’ve never seen a model of the diseases that I’ve dealt with where the worst case actually came out. They always overshoot,” Dr. Fauci explained.
The leading infectious diseases expert went on to predict that the country could have a million cases of the coronavirus and that the number of deaths from the pandemic could reach up to 100,000. “I mean, looking at what we’re seeing now, I’d say 100 to 200,000. But I don’t want to be held to that,” said Dr. Fauci.
The United States is now currently the country with the highest number of cases, which also saw 2,000 deaths in a span of two days. The drastic rise also resulted in a shortage of supplies in health facilities, especially in New York, the state with the highest number of cases. This resulted in lockdowns, forcing Americans to practice social distancing and self-quarantine or self-isolation for 15 days. However, Dr. Fauci believes that even after the 15 days, the social distancing will continue.
Dr. Fauci said that it would take more than 15 days before the country is set to pull back the restrictions. “We’ll look at it, and if we need to push the date forward, we will push the date forward,”
“It’s going to be a matter of weeks. It’s not going to be tomorrow, and it’s certainly not going to be next week. It’s going to be a little bit more than that.”


Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



